Showing results (61-70 of 97) with videos related to

Sort By:
Pageof 10
Nephrology (Carlton, Vic.)|December 25, 2018
Insufficiency of urinary acid excretion of overweight or obese patients with chronic kidney disease and its involvement with renal tubular injuryKoji Eguchi, Yuichiro Izumi, Yushi Nakayama, et al.
Clinical Pediatric Endocrinology : Case Reports and Clinical Investigations : Official Journal of the Japanese Society for Pediatric Endocrinology|February 14, 2015
A 45,X/46,XY DSD (Disorder of Sexual Development) case with an extremely uneven distribution of 46,XY cells between lymphocytes and gonadsRisa Nomura, Kentaro Miyai, Michiyo Okada, et al.
Biochemistry and Biophysics Reports|December 25, 2019
G790del mutation in DSC2 alone is insufficient to develop the pathogenesis of ARVC in a mouse modelYoriomi Hamada, Takeshi Yamamoto, Yoshihide Nakamura, et al.
Endocrine Journal|August 23, 2016
Lower body weight and BMI at birth were associated with early adiposity rebound in 21-hydroxylase deficiency patientsShigeru Takishima, Keisuke Nakajima, Risa Nomura, et al.
American Journal of Physiology. Renal Physiology|December 28, 2023
Characterization of gene expression in the kidney of renal tubular cell-specific NFAT5 knockout miceMakoto Ono, Yuichiro Izumi, Kosuke Maruyama, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|October 15, 2010
Dantrolene, a therapeutic agent for malignant hyperthermia, inhibits catecholaminergic polymorphic ventricular tachycardia in a RyR2(R2474S/+) knock-in mouse modelShigeki Kobayashi, Masafumi Yano, Hitoshi Uchinoumi, et al.
Journal of the American Geriatrics Society|September 6, 2008
Elevated C-reactive protein is related to cognitive decline in older adults with cardiovascular diseaseKarin F Hoth, Andreana P Haley, John Gunstad, et al.
Journal of the American College of Cardiology|May 23, 2009
Dantrolene, a therapeutic agent for malignant hyperthermia, markedly improves the function of failing cardiomyocytes by stabilizing interdomain interactions within the ryanodine receptorShigeki Kobayashi, Masafumi Yano, Takeshi Suetomi, et al.
Biochemical and Biophysical Research Communications|April 24, 2014
Enhanced binding of calmodulin to RyR2 corrects arrhythmogenic channel disorder in CPVT-associated myocytesMasakazu Fukuda, Takeshi Yamamoto, Shigehiko Nishimura, et al.
Biomolecules|August 8, 2020
Long QT Syndrome Type 2: Emerging Strategies for Correcting Class 2 KCNH2 (hERG) Mutations and Identifying New PatientsMakoto Ono, Don E Burgess, Elizabeth A Schroder, et al.
Pageof 10